Peripheral Vascular Stents Segment Held Highest Share of Product Segment in Peripheral Vascular Devices Market in 2021
According to our new research study on "Peripheral Vascular Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product and End User," the market is expected to grow from US$ 11,375.13 million in 2021 to US$ 17,679.72 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The report highlights trends prevailing in the market and drivers and hindrances pertaining to the market growth.
Market Overview
Peripheral vascular disorders, such as peripheral artery occlusive disease (PAOD), peripheral artery disease (PAD), and peripheral obliterative arteriopathy, result from the growth of atherosclerotic plaques in arteries that supply blood to organs, limbs, and the head. These disorders affect the peripheral veins and arteries as well as the peripheral and cardiac circulation. Peripheral vascular devices, including inferior vena cava (IVC) filters, angiography catheters, Endovascular Aneurysm Repair (EVAR) stent grafts, hemodynamic flow alteration, and plaque modification devices, are used in peripheral endovascular and coronary procedures to treat peripheral arterial or coronary arterial disease. Their use aims to minimize surgical interference while causing the least amount of disruption during the operation.
Market Dynamics
The satellite communication terminal market is expanding due to increased public safety concerns and the need for a dependable network during emergencies. Additionally, the growth of over-the-top (OTT) and internet protocol television (IPTV) is driving the satellite industry, leading to increased demand for SATCOM communication and hardware, including terminals. Despite this growth, high implementation costs, restricted data transit capabilities, and limited spectrum bandwidth are limiting market expansion. Government investment in mission-critical communication systems in the defense sector, however, is expected to create promising opportunities for the industry in the future.
Market Segmentation
The peripheral vascular devices market is categorized by product into atherectomy devices, chronic total occlusion devices, embolization guidewires, peripheral transluminal angioplasty balloon catheters, peripheral vascular stents, PTA guidewires, synthetic surgical grafts, and aortic stents. End users of the market include ambulatory care centers, hospitals and clinics, specialty clinics, and others. The market is further divided geographically into North America (Canada, Mexico, and the US), Europe (France, Germany, Italy, Spain, the UK, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Argentina, Brazil, and the Rest of SCAM).
Key Companies
The peripheral vascular devices market is competitive with both small and large companies. Market players use strategies such as technological advancements, new product launches, and geographic expansion to boost their market share. Terumo Corporation launched the Aortic Balloon in the US in December 2021, which allows physicians to expand the aorta during endovascular aortic repair with TREO and RELAY stent grafts. Top companies operating in the peripheral vascular devices market include Abbott, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, Boston Scientific Corporation, BD, Cook Medical LLC, Terumo Corporation, B. Braun Melsungen AG, and Cardinal Health Inc.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com